Brief: Cue Biopharma Announces Chief Medical Officer Transition
23/01/2023 13:17
Jan 23 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA ANNOUNCES CHIEF MEDICAL OFFICER TRANSITION
* CUE BIOPHARMA INC - MATTEO LEVISETTI, M.D., PROMOTED TO
CHIEF
MEDICAL OFFICER
Source text for Eikon: ID:nGNX9HdxqS
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria